Abstract The aim of this study is to identify the factors associated with mortality in patients with COVID-19 undergoing invasive mechanical ventilation at a university hospital in Northeastern Brazil. This is a retrospective cohort from April to August 2020 through an analysis of medical records, considering the demographic profile, comorbidities, complications, supports, respiratory and laboratory parameters. A total of 65 patients required invasive mechanical ventilation, of which 64.6% died in the ICU. They were older, had more comorbidities, shorter length of stay in the intensive care unit, received more support such as palliative care and two vasopressors simultaneously, showed lower levels of pH, hemoglobin and calcium, and higher levels of bicarbonate, lactate, prothrombin time, international normalized ratio, troponin and ferritin at the start of invasive mechanical ventilation. Furthermore, the time course of pH, arterial oxygen partial pressure to fractional inspired oxygen ratio, arterial carbon dioxide partial pressure, lactate, hemoglobin, platelets, lymphocytes, neutrophil-to-lymphocyte ratio, coagulation parameters, calcium, urea, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, ferritin, static compliance, airway resistance, tidal volume, and noradrenaline doses showed association with mortality. There was a high mortality rate in invasively mechanically ventilated COVID-19 patients, with some associated factors identified at the start of invasive mechanical ventilation and others identified over time. COVID19 COVID 19 COVID-1 Brazil 202 records profile comorbidities complications supports parameters 6 646 64 64.6 ICU older unit simultaneously pH calcium bicarbonate lactate ratio Furthermore platelets lymphocytes neutrophiltolymphocyte neutrophil lymphocyte urea aminotransferase phosphatase compliance resistance volume COVID1 1 COVID- 20 64. 2

Abstract Background Temporal lobe epilepsy (TLE) is a high prevalence neurological disorder. Surgery has emerged as a promising treatment. Objective The objective of this work is to compare the surgical results of anterior temporal lobectomy (ATL) versus selective amygdalohippocampectomy (SAH) in a cohort of 132 patients. Methods We performed a retrospective study of 146 patients operated for TLE from 2008 to 2019. Initially, 13 patients were excluded from the study due to insufficient medical record data or follow-up loss. One patient was excluded from the analysis of the results due to death in the first postoperative week. We used the ILAE scale to classify seizure control after surgery. In patients with left hippocampal sclerosis, SAH was performed and in right temporal lobe epilepsy, ATL was the approach of choice. Results The mean follow-up time after surgery was 57.2 months (12–137). In our data analysis, we found that the group of patients undergoing ATL had a higher prevalence of being completely seizure-free (ILAE I) (57.1% versus 31%) and a higher rate of satisfactory seizure control (88.6% versus 69.3%) p = 0,006, when compared with patients undergoing SAH. Conclusions The literature is still controversial about seizure control concerning the technique used due to the lack of a robust methodology. Our data analysis identified the superiority of ATL over SAH in seizure outcomes. ATL may be the best option for adequately controlling seizures with minimal additional morbidity in countries with a cost limitation for extended propaedeutics. (TLE disorder treatment (ATL (SAH 14 200 2019 Initially 1 followup follow up loss week sclerosis choice 572 57 2 57. 12–137. 12137 12–137 . 12 137 (12–137) seizurefree free I 57.1% 571 (57.1 31% 31 88.6% 886 88 6 (88.6 69.3% 693 69 3 0006 0 006 0,006 methodology outcomes propaedeutics 20 201 5 1213 12–13 (12–137 57.1 (57. 88.6 8 (88. 69.3 000 00 0,00 121 12–1 (12–13 (57 88. (88 69. 0,0 12– (12–1 (5 (8 0, (12– ( (12 (1

Resumo Antecedentes A epilepsia do lobo temporal (TLE) é uma desordem neurológica de alta prevalência. A cirurgia surgiu como um tratamento promissor. Objetivo O objetivo deste trabalho é comparar os resultados da lobectomia temporal anterior (ATL) versus amigdalohipocampectomia seletiva (SAH) em uma coorte de 132 pacientes. Métodos Realizamos um estudo retrospectivo de 146 pacientes operados por TLE de 2008 a 2019. Inicialmente, 13 pacientes foram excluídos por insuficiência de dados em prontuário ou perda de seguimento. Um paciente foi excluído da análise por óbito na primeira semana de pós-operatório. Usamos a escala ILAE para classificar o controle das crises após a cirurgia. Em pacientes com esclerose hipocampal à esquerda, foi realizada a SAH, e na epilepsia do lobo temporal à direita, a ATL foi a abordagem de escolha. Resultados O tempo médio de seguimento após a cirurgia foi de 57,2 meses (12–137). Em nossa avaliação, encontramos que o grupo de pacientes submetidos à ATL apresentou maior prevalência de ausência total de crises (ILAE I) (57,1% versus 31%) e maior taxa de controle satisfatório da epilepsia (88,6% versus 69,3%) p = 0,006, quando comparado ao grupo submetido à SAH. Resultados A literatura ainda é controversa em relação à redução das crises de acordo com a técnica utilizada devido a falta de uma metodologia robusta. Nosso estudo identificou superioridade da ATL sobre a SAH nos desfechos convulsivos. ATL pode ser a melhor opção para controlar adequadamente as convulsões com morbidade adicional mínima em países com limitação de custo para propedêutica estendida. (TLE promissor (ATL (SAH 14 200 2019 Inicialmente 1 pósoperatório. pósoperatório pós operatório. operatório pós-operatório esquerda direita escolha 572 57 2 57, 12–137. 12137 12–137 . 12 137 (12–137) avaliação I 57,1% 571 (57,1 31% 31 88,6% 886 88 6 (88,6 69,3% 693 69 3 0006 0 006 0,006 robusta convulsivos estendida 20 201 5 1213 12–13 (12–137 57,1 (57, 88,6 8 (88, 69,3 000 00 0,00 121 12–1 (12–13 (57 88, (88 69, 0,0 12– (12–1 (5 (8 0, (12– ( (12 (1

Abstract: This study aimed to compare the use of connective tissue grafts (CTG) and platelet-rich fibrin (PRF) associated with the tunnel technique (TT) for the treatment of multiple gingival recessions (GR). Fourteen patients with multiple bilateral GR [type 1 recession (RT 1)] in the maxillary incisors, canines, and/or premolars were included. The TT was performed on both sides (split-mouth model); CTG (36 GR) was used on one side, and on the other, PRF (36 GR) was used. Clinical parameters, including recession depth (RD), probing depth, clinical attachment level (CAL), and keratinized gingiva thickness/width (GT/KTW), were obtained at baseline and after 1, 3, 6, and 16 months. Lower RD (0.81 ± 0.68 vs. 1.23 ± 0.71 mm) and CAL (2.54 ± 0.63 vs. 2.73 ± 0.82 mm) were observed for CTG compared to PRF after 16 months. Higher GT was obtained for CTG compared to PRF after 3 (1.81 ± 0.56 vs 1.43 ± 0.47 mm) and 6 months (1.67 ± 0.61 vs. 1.38 ± 0.55 mm, p < 0.05). The recession coverage (RC) was higher for CTG (55.42% ± 37.14) in comparison to PRF (29.53% ± 34.08) after 16 months (p < 0.05). Similarly, CTG presented a more complete coverage of the recession (15; 41.66%) than PRF (9; 24.32%). There were no significant differences between the groups in terms of surgery time, postoperative pain, or healing patterns. Greater esthetic satisfaction was obtained with CTG. It was concluded that CTG combined with TT showed clinical and esthetic results superior to those of PRF in multiple GR treatments. Abstract (CTG plateletrich platelet rich (PRF (TT GR. . (GR) type RT 1) incisors canines andor included splitmouth split mouth model model) 36 (3 side other parameters RD, , (RD) CAL, (CAL) thicknesswidth thickness width GT/KTW, GTKTW GT/KTW KTW (GT/KTW) 0.81 081 0 81 (0.8 068 68 0.6 123 23 1.2 071 71 0.7 mm 2.54 254 2 54 (2.5 063 63 273 73 2.7 082 82 0.8 1.81 181 (1.8 056 56 0.5 143 43 1.4 047 47 0.4 1.67 167 67 (1.6 061 61 138 38 1.3 055 55 0.05. 005 0.05 05 0.05) RC (RC 55.42% 5542 42 (55.42 37.14 3714 37 14 29.53% 2953 29 53 (29.53 34.08 3408 34 08 Similarly 15 (15 41.66% 4166 41 66 9 (9 24.32%. 2432 24.32% 24 32 24.32%) time pain patterns treatments (GR ( (RD (CAL (GT/KTW 8 (0. 06 0. 12 1. 07 7 2.5 25 5 (2. 27 2. 1.8 18 (1. 4 04 1.6 13 00 0.0 55.42 554 (55.4 37.1 371 29.53 295 (29.5 34.0 340 (1 41.66 416 243 24.32 (0 (2 55.4 (55. 37. 29.5 (29. 34. 41.6 24.3 55. (55 29. (29 41. 24. (5

INTRODUÇÃO: Estudo retrospectivo com o objetivo de avaliar a ocorrência de doações inaptas para doença de Chagas entre 1995 e 2009 no Hemocentro Regional de Uberaba (HRU), Brasil; verificar a tendência dessa inaptidão e descrever o perfil epidemiológico dos doadores. MÉTODOS: Estudo retrospectivo da inaptidão sorológica para doença de Chagas; análise estatística pelo teste do qui quadrado e odds ratio; estudo de tendência a partir do gráfico de dispersão e do coeficiente de correlação linear (r). RESULTADOS: No período em estudo foi encontrada uma soroprevalência de inaptidão para doença de Chagas de 0.2% com queda significativa de doações inaptas de 2001 a 2009. Dentre os soropositivos, observou-se predomínio significante na idade superior ou igual a 30 anos, e estado civil casado e outros. CONCLUSÕES: Os resultados demonstram taxa de ocorrência menor que as descritas na literatura, além de queda progressiva no decorrer dos 15 anos avaliados. Tais resultados são consequência do combate sistemático ao vetor a partir dos anos 70 e do progressivo e consistente aumento de doadores de retorno, resultando em queda do risco de contaminação via transfusão de sangue e na melhora da qualidade da hemoterapia praticada no HRU.

INTRODUCTION: A retrospective study was conducted to assess the occurrence of blood donations that were ineligible due to Chagas disease infection from 1995 to 2009 at the Uberaba Regional Blood Center (HRU), Brazil, verify the tendency of this ineligibility, and describe the epidemiologic profile of the donors. METHODS: Retrospective studies of serological ineligibility due to Chagas disease, statistical analysis by means of the chi-square test and odds ratio, study of the tendencies using a dispersion graph and the linear correlation coefficient (r) were performed. RESULTS: In the period under study, a 0.2% serum prevalence of ineligibility due to Chagas disease was found, with a significant drop in ineligible donations from 2001 to 2009. Among the serum positive-donors, there was a significant predominance among those aged 30 years or above and non-single individuals. CONCLUSIONS: The results show a rate of occurrence that is lower than that described in literature, as well as a progressive drop during the 15 years under assessment. Such results are a consequence of systematic combat of the vector since the 70s and the progressive and consistent increase of returning donors, resulting in a drop of the contamination risk factor by means of blood transfusion and in the improvement of the quality of hemotherapy practices in the HRU.

Um total de 47 vertebroplastias percutâneas (VP) foram realizadas para fraturas vertebrais osteoporóticas em 31 pacientes, 25 VP foram realizadas usando-se a cânula de orifício frontal (COF) e 22 com a nova cânula de orifício lateral (COL), distribuídos randomicamente. A incidência de extrusão de cimento ortopédico ocorreu em 27% com a COL, e 68% com a COF, todas assintomáticas (p<0,01). O controle da dor foi similar em ambos os grupos, com boa melhora da dor na maioria dos pacientes, sem complicações clínicas relevantes. A extrusão do cimento pode ser significativamente reduzida com esta nova COL, que permite uma melhor injeção do cimento para o centro do corpo vertebral, aumentando a segurança do procedimento, sem aumento no seu custo.

A total of 47 percutaneous vertebroplasties (PVs) were performed for osteoporotic vertebral fractures in 31 patients, 25 PVs were performed using the frontal-opening cannula (FOC) and 22 using the new side-opening cannula (SOC), randomly distributed. The incidence of cement extrusion was 27% with the SOC, and 68% with the FOC, all asymptomatic (p<0.01). The pain control was similar for both groups, with good improvement of pain in most of the patients, and there were no clinical relevant complications. The cement leakage can be significantly reduced with this new SOC, which allows for a better cement injection toward the center of the vertebral body, increasing the safety of the procedure, with no increase in cost.